Viron Therapeutics is a clinical stage biopharmaceutical company pioneering the development of viral proteins to treat and prevent human inflammatory disorders. Viral proteins represent a revolutionary new class of drugs. By harnessing the evolutionary power of viruses and other pathogens to evade the human body's protective inflammatory response, Viron is able to identify and develop powerful protein therapeutics that have distinct advantages in potency and efficacy over conventional drug therapy. Viron is the first company to successfully advance a viral protein drug into human testing.
Trudell Medical International (TMI) develops and manufactures pharmaceutical aerosol drug...
Amgen engages in the development of human therapeutic products in supportive of cancer care,...
Labor Sponsored Devpt Fund
Canadian Venture Capital Firm
BDC Venture Capital is a major venture capital investor in Canada, active at every stage of the...
700 Collip Circle, Suite 203
London, N6G 4X8